OTCMKTS:RLMD

Relmada Therapeutics Stock Predictions

etoro logo Buy RLMD
*Your capital is at risk
$6.33
-0.0900 (-1.40%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

RLMD Prediction Chart

RLMD Predictions History

Latest community submissions for RLMD.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 14, 2025 $2.12 +5.03% $1.93 X 90.07% 0
Oct 14, 2025 $2.08 +3.14% $1.93 X 92.05% 0
Oct 14, 2025 Bullish $1.93 X 0
Apr 25, 2025 $0.709 -3.79% $0.645 V 90.04% 1
Apr 25, 2025 $0.720 -2.37% $0.645 V 88.41% 1
Apr 25, 2025 Bullish $0.645 X 0
Apr 25, 2025 $0.660 -10.48% $0.645 V 97.69% 1
Apr 24, 2025 $0.666 -3.41% $0.737 X 90.39% 0
Apr 24, 2025 $0.675 -2.13% $0.737 X 91.59% 0
Sep 5, 2023 $3.67 +287.56% Unrealistic Excluded from avg $3.78 X 97.15% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RLMD with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT RELMADA THERAPEUTICS, INC.
Relmada Therapeutics
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE